HIGHLIGHTS
- who: Hideo Wada from the (UNIVERSITY) have published the article: Application of a scoring system in Japanese patients diagnosed with atypical hemolytic uremic syndrome to assess the relationship between the score and clinical responses to eculizumab, in the Journal: (JOURNAL)
- what: In contrast, this study determined a TMA/aHUS score by scoring thirteen clinically relevant items across three sections (TMA score, positive aHUS score, and exclusion aHUS score), and then calculating a sum of these three sections to simplify the analysis of comparing responses to eculizumab. In the present study, patients who were clinically diagnosed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.